Literature DB >> 1352035

Identification of two affinity states of low affinity receptors for Escherichia coli heat-stable enterotoxin: correlation of occupation of lower affinity state with guanylate cyclase activation.

M R Crane1, M Hugues, P D O'Hanley, S A Waldman.   

Abstract

Two distinct affinity states of low affinity Escherichia coli heat-stable enterotoxin (ST) receptors in rat intestinal membranes, with dissociation constants of 0.12 and 2.5 nM, were identified. Kinetic binding studies demonstrated biphasic association kinetics, whereas dissociation was unimodal. These studies also confirmed that ligand bound to each receptor state in an independent bimolecular reaction. In contrast, equilibrium binding studies yielded linear Scatchard plots, indicative of a single class of noninteractive binding sites, with a Kd = 2.3 nM. Close agreement of the dissociation constants determined by kinetic and equilibrium methods suggested that receptors were in the lower affinity state at equilibrium. Several models, including binding site heterogeneity, cooperativity, and ligand-induced alterations in receptor conformation were inconsistent with these observations. Indeed, these data were most consistent with a two-step binding process involving a third component. Comparison of the ligand dependence of enzyme activation (EC50 = 124 nM) and the calculated fractional receptor occupancy of the lower affinity component at 5 min (EC50 = 40 nM) demonstrated that occupation of the lower affinity state of low affinity ST receptors correlated with guanylate cyclase activation. The close correlation between receptor occupation and enzyme activation suggests that there are no spare receptors for ST in intestinal membranes. These data resolve the previously observed discrepancy between the affinity of receptors for ST and the potency of this ligand for activating guanylate cyclase. Receptor affinity state alterations may represent a common mechanism for receptor-effector coupling of particulate guanylate cyclases.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1352035

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  10 in total

Review 1.  E. coli heat-stable enterotoxin and guanylyl cyclase C: new functions and unsuspected actions.

Authors:  Ralph A Giannella; Elizabeth A Mann
Journal:  Trans Am Clin Climatol Assoc       Date:  2003

Review 2.  Heat-stable enterotoxin of enterotoxigenic Escherichia coli as a vaccine target.

Authors:  Arne Taxt; Rein Aasland; Halvor Sommerfelt; James Nataro; Pål Puntervoll
Journal:  Infect Immun       Date:  2010-03-15       Impact factor: 3.441

Review 3.  Regulation and therapeutic targeting of peptide-activated receptor guanylyl cyclases.

Authors:  Lincoln R Potter
Journal:  Pharmacol Ther       Date:  2010-12-24       Impact factor: 12.310

4.  Guanylyl cyclase C agonists regulate progression through the cell cycle of human colon carcinoma cells.

Authors:  G M Pitari; M D Di Guglielmo; J Park; S Schulz; S A Waldman
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-03       Impact factor: 11.205

5.  125I-Labelled mapacalcine: a specific tool for a pharmacological approach to a receptor associated with a new calcium channel on mouse intestinal membranes.

Authors:  P Vidalenc; J L Morel; J Mironneau; M Hugues
Journal:  Biochem J       Date:  1998-04-01       Impact factor: 3.857

Review 6.  Structure and function of the heat-stable enterotoxin receptor/guanylyl cyclase C.

Authors:  Arie B Vaandrager
Journal:  Mol Cell Biochem       Date:  2002-01       Impact factor: 3.396

7.  Receptor guanylyl cyclase C (GC-C): regulation and signal transduction.

Authors:  Nirmalya Basu; Najla Arshad; Sandhya S Visweswariah
Journal:  Mol Cell Biochem       Date:  2009-12-04       Impact factor: 3.396

8.  STa peptide analogs for probing guanylyl cyclase C.

Authors:  Xiaobing Tian; Allison M Michal; Peng Li; Henry R Wolfe; Scott A Waldman; Eric Wickstrom
Journal:  Biopolymers       Date:  2008       Impact factor: 2.505

9.  Role of uroguanylin's signalling pathway in the development of ischaemic stroke.

Authors:  Martina Ratko; Nikola Habek; Marina Dobrivojević Radmilović; Siniša Škokić; Helena Justić; Anja Barić; Aleksandra Dugandžić
Journal:  Eur J Neurosci       Date:  2022-05-04       Impact factor: 3.698

Review 10.  Current understanding of guanylin peptides actions.

Authors:  Aleksandra Sindic
Journal:  ISRN Nephrol       Date:  2013-04-17
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.